NYSE · DD
Basic Materials · Chemicals
$140.05▼ 0.38% ($0.53)at close
As of 4:00 PM ET
Valuation
Verdict: expensive. Price above all scenarios.
The price needs 2.7% free cash flow growth a year for 5 years. Our scenarios assume −36.8–−7.6%.
Its past 10 years averaged −22.6% a year.
Value per share
Base case
$34.17
Price used $140.05 is 4.1× this
USD · TTM ending Jun 30, 2026 · Price Oct 30, 8:00 PM UTC
FCFF base normalized by replacing latest capex with the company's trailing median capex-to-revenue ratio.
Historical FCFF CAGR and the default growth rates are taken from the raw historical series. The valuation base is normalized for the current-period DCF.
Free cash flow each value needs
Free cash flow today $1.1B. The price needs $1.5B by 2036. Base case: $378M. At its recent pace: $88.4M. Bear to Bull: $137M to $916M.
$1.5B
What the price needs
2.7% a year for 5 yrs · by 2036
$88.4M
At its recent pace
−22.6% a year
+$1.2B
more free cash flow in 2036 than the Base case expects
$378M
Base case → $34.17/share
Free cash flow today $1.1B. The price needs $1.5B by 2036. Base case: $378M. At its recent pace: $88.4M. Bear to Bull: $137M to $916M.
Free cash flow in 2036
today $1.1B
+$1.2Bmore than the Base case · 4.1×
Value per share · Base case
$34.17
Price $140.05
4.1× this
FCFF base normalized by replacing latest capex with the company's trailing median capex-to-revenue ratio.
Historical FCFF CAGR and the default growth rates are taken from the raw historical series. The valuation base is normalized for the current-period DCF.
USD · TTM ending Jun 30, 2026 · Price Oct 30, 8:00 PM UTC
What each scenario assumes. Click a column to start from it.
Price vs Fundamentals
The stock rose 37.02% over the last year. Revenue declined 32.68% over the trailing twelve months. Operating margin moved from 16.27% to 14.71%. Free cash flow declined 14.67% over the trailing twelve months.
The stock is rising despite deteriorating fundamentals and now sits at the 74th percentile of its historical P/FCF range. This is a momentum-driven move — the market may be front-running a recovery that has not yet appeared in reported numbers.
Operating margin (currently 14.71%) would need to stabilize or improve to justify the move. Revenue is declining 32.68% — a trend reversal in the next report would be the key signal to watch. This read is wrong if the next period shows operating metrics turning the corner. At that point the price would be anticipating real improvement rather than running ahead of it.
Company profile
DuPont de Nemours, Inc. is a global provider of advanced materials and innovative solutions, serving markets across North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific region.
Market multiples
Stock splits
Every 3 shares became 1
Every 100 shares became 239
Every 400 shares became 189
Every 1000 shares became 1487
Every 1 shares became 3
Every 2 shares became 3
Every 1 shares became 2
Every 1 shares became 2
Profitability & growth
Analyst consensus
23
Buy
17
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Actuals vs estimates by quarter, or any quarter against the same one a year earlier.
Next report
Nov 3, 2026
Q3 FY26 · EPS est $1.87 · Revenue est $1.8B
Same quarter, year over year
FY26 YTD -0.8%Each cell vs the same quarter a year earlier (the cell below) · Q1–Q2 combined $3.53 vs $3.56 · 1 of 2 quarters up
Q1
Q2
Q3
Q4
FY total
FY26
—
—
FY25
FY24
FY23
—
—
—
Fiscal year totals
Q2 FY26
Reported Aug 4, 2026 · Latest
HoverTap a cell to inspect
Actual
$1.88
Estimate
$1.76
Year over year
+301.4%
Vs prior quarter
+13.9%
DuPont de Nemours, Inc. · DD
From Form 13F filings (managers with $100M+). Filings land up to 45 days after quarter end — read this as positioning context, not live fund flow.
Market cap
$18.91B
P/E
349.36
EPS (TTM)
$0.40
Next earnings
Nov 3, 2026